CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback